HIV Prevention for HIV-Negative Men Via Reduction of Social Anxiety

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Social AnxietySubstance Use
Interventions
BEHAVIORAL

Reduction of social anxiety & substance use in gay/bi men

The study will provide Phase I trial data for a novel and innovative HIV prevention intervention for MSM built upon empirically supported interventions to reduce HIV risk among MSM and cognitive-behavioural therapy to reduce social anxiety. This study will test a novel integrated HIV prevention intervention that combines empirically supported treatments for social anxiety with HIV risk reduction counseling to reduce HIV sexual risk behaviour. Study objectives: 1) to provide data on the acceptability/feasibility of the intervention, 2) to provide data to test the intervention, and 3) to provide data that will allow for a RCT that will test intervention efficacy relative to HIV prevention interventions that do not reduce social anxiety or substance use in sexual situations.

Trial Locations (1)

M5B1G8

Ryerson University, Toronto

All Listed Sponsors
lead

Toronto Metropolitan University

OTHER

NCT02045225 - HIV Prevention for HIV-Negative Men Via Reduction of Social Anxiety | Biotech Hunter | Biotech Hunter